The immunomodulating role of exercise in metabolic disease

Trends in Immunology

Volumn 35, Issue 6, 2014, Pages 262-269

  Lancaster, Graeme I ^a   Febbraio, Mark A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Anti inflammatory; Exercise; Immune cells; Inflammation; Metabolic disease; Muscle

Indexed keywords

C REACTIVE PROTEIN; CHEMOTACTIC FACTOR; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TOLL LIKE RECEPTOR;

ADAPTATION; ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPETITIVE INHIBITION; EXERCISE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; INSULIN RESISTANCE; LIPID STORAGE; MARATHON RUNNER; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; REVIEW; SKELETAL MUSCLE; TRIATHLON; ANIMAL; IMMUNITY; IMMUNOLOGY; LIPID METABOLISM; LIVER; METABOLISM; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANIMALS; EXERCISE; HUMANS; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; INTERLEUKIN-1; LIPID METABOLISM; LIVER; METABOLIC DISEASES; MUSCLE, SKELETAL; OBESITY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84901632923     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.02.008     Document Type: Review

References (83)

1. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
2. Booth F.W., et al. Lack of exercise is a major cause of chronic diseases. Comp. Physiol. 2012, 2:1143-1211.
3. Handschin C., Spiegelman B.M. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature 2008, 454:463-469.
4. Knowler W.C., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002, 346:393-403.
5. Krogh-Madsen R., et al. Normal physical activity obliterates the deleterious effects of a high-caloric intake. J. Appl. Physiol. (1985) 2013, 116:231-239.
6. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab. 2013, 17:851-859.
7. Libby P., et al. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013, 38:1092-1104.
8. Osborn O., Olefsky J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012, 18:363-374.
9. Gleeson M. Immune function in sport and exercise. J. Appl. Physiol. (1985) 2007, 103:693-699.
10. Walsh N.P., et al. Position statement. Part one: immune function and exercise. Exerc. Immunol. Rev. 2011, 17:6-63.
11. Jeukendrup A.E., et al. Relationship between gastro-intestinal complaints and endotoxaemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin. Sci. (Lond.) 2000, 98:47-55.
12. Ostrowski K., et al. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J. Physiol. 1999, 515:287-291.
13. Starkie R., et al. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 2003, 17:884-886.
14. Gleeson M., et al. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat. Rev. Immunol. 2011, 11:607-615.
15. Lumeng C.N., et al. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117:175-184.
16. Wu D., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
17. + effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15:914-920.
18. Talukdar S., et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat. Med. 2012, 18:1407-1412.
19. Winer D.A., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 2011, 17:610-617.
20. Patsouris D., et al. Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 2008, 8:301-309.
21. Sun K., et al. Adipose tissue remodeling and obesity. J. Clin. Invest. 2011, 121:2094-2101.
22. Jung D.Y., et al. Short-term weight loss attenuates local tissue inflammation and improves insulin sensitivity without affecting adipose inflammation in obese mice. Am. J. Physiol. Endocrinol. Metab. 2013, 304:E964-E976.
23. + T cells in the adipose tissue of obese mice. Med. Sci. Sports Exerc. 2013, 45:1684-1693.
24. Kawanishi N., et al. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc. Immunol. Rev. 2010, 16:105-118.
25. Vieira V.J., et al. Effects of exercise and low-fat diet on adipose tissue inflammation and metabolic complications in obese mice. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E1164-E1171.
26. Bruun J.M., et al. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E961-E967.
27. Auerbach P., et al. Differential effects of endurance training and weight loss on plasma adiponectin multimers and adipose tissue macrophages in younger, moderately overweight men. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2013, 305:R490-R498.
28. Park E.J., et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010, 140:197-208.
29. Petrasek J., et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J. Clin. Invest. 2012, 122:3476-3489.
30. Arkan M.C., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 2005, 11:191-198.
31. Cai D., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 2005, 11:183-190.
32. Huang W., et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010, 59:347-357.
33. Johnson N.A., et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 2009, 50:1105-1112.
34. Sullivan S., et al. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 2012, 55:1738-1745.
35. Haus J.M., et al. Improved hepatic lipid composition following short-term exercise in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 2013, 98:E1181-E1188.
36. Kawanishi N., et al. Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice. Brain Behav. Immun. 2012, 26:931-941.
37. Fink L.N., et al. Expression of anti-inflammatory macrophage genes within skeletal muscle correlates with insulin sensitivity in human obesity and type 2 diabetes. Diabetologia 2013, 56:1623-1628.
38. Fink L.N., et al. Pro-inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans. Obesity (Silver Spring) 2014, 22:747-757.
39. Hirosumi J., et al. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
40. Sabio G., et al. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance. Mol. Cell Biol. 2010, 30:106-115.
41. Sparks L.M., et al. Nine months of combined training improves ex vivo skeletal muscle metabolism in individuals with type 2 diabetes. J. Clin. Endocrinol. Metab. 2013, 98:1694-1702.
42. Louche K., et al. Endurance exercise training up-regulates lipolytic proteins and reduces triglyceride content in skeletal muscle of obese subjects. J. Clin. Endocrinol. Metab. 2013, 98:4863-4871.
43. Samokhvalov V., et al. Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E37-E46.
44. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
45. Konner A.C., Bruning J.C. Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol. Metab. 2011, 22:16-23.
46. Seneviratne A.N., et al. Toll-like receptors and macrophage activation in atherosclerosis. Clin. Chim. Acta 2012, 413:3-14.
47. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
48. Nguyen M.T., et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 2007, 282:35279-35292.
49. Shi H., et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116:3015-3025.
50. Pal D., et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. 2012, 18:1279-1285.
51. Stewart C.R., et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 2010, 11:155-161.
52. Higashimori M., et al. Role of Toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2011, 31:50-57.
53. Michelsen K.S., et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10679-10684.
54. Kraus W.E., et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med. 2002, 347:1483-1492.
55. Mori K., et al. Fetuin-A and the cardiovascular system. Adv. Clin. Chem. 2012, 56:175-195.
56. Stefan N., Haring H.U. The role of hepatokines in metabolism. Nat. Rev. Endocrinol. 2013, 9:144-152.
57. Jenkins N.T., et al. Plasma fetuin-A concentrations in young and older high- and low-active men. Metabolism 2011, 60:265-271.
58. Malin S.K., et al. Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. J. Appl. Physiol. (1985) 2013, 115:988-994.
59. Lancaster G.I., et al. The physiological regulation of Toll-like receptor expression and function in humans. J. Physiol. 2005, 563:945-955.
60. Flynn M.G., et al. Toll-like receptor 4 and CD14 mRNA expression are lower in resistive exercise-trained elderly women. J. Appl. Physiol. (1985) 2003, 95:1833-1842.
61. McFarlin B.K., et al. TLR4 is lower in resistance-trained older women and related to inflammatory cytokines. Med. Sci. Sports Exerc. 2004, 36:1876-1883.
62. Oliveira M., Gleeson M. The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthy men. Eur. J. Appl. Physiol. 2010, 109:251-257.
63. Simpson R.J., et al. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans. Brain Behav. Immun. 2009, 23:232-239.
64. + cell-surface expression of Toll-like receptor 2 and 4. Brain Behav. Immun. 2005, 19:389-397.
65. +) monocytes: a role in the anti-inflammatory influence of exercise?. J. Leukoc. Biol. 2008, 84:1271-1278.
66. Reyna S.M., et al. Short-term exercise training improves insulin sensitivity but does not inhibit inflammatory pathways in immune cells from insulin-resistant subjects. J. Diabetes Res. 2013, 10.1155/2013/107805.
67. Wu X.D., et al. Effect of aerobic exercise on miRNA-TLR4 signaling in atherosclerosis. Int. J. Sports Med. 2013, 10.1055/s-0033-1349075.
68. Oliveira A.G., et al. Physical exercise reduces circulating lipopolysaccharide and TLR4 activation and improves insulin signaling in tissues of DIO rats. Diabetes 2011, 60:784-796.
69. Jeppesen J., Kiens B. Regulation and limitations to fatty acid oxidation during exercise. J. Physiol. 2012, 590:1059-1068.
70. Zbinden-Foncea H., et al. TLR2 and TLR4 activate p38 MAPK and JNK during endurance exercise in skeletal muscle. Med. Sci. Sports Exerc. 2012, 44:1463-1472.
71. Starkie R.L., et al. Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running. Am. J. Physiol. Cell Physiol. 2001, 280:C769-C774.
72. Dinarello C.A., et al. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat. Rev. Drug Discov. 2012, 11:633-652.
73. Wen H., et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011, 12:408-415.
74. Masters S.L., et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat. Immunol. 2010, 11:897-904.
75. Freigang S., et al. Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis. Nat. Immunol. 2013, 14:1045-1053.
76. Ridker P.M., et al. Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation 2012, 126:2739-2748.
77. Steensberg A., et al. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 2000, 529:237-242.
78. Pedersen B.K., Febbraio M.A. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat. Rev. Endocrinol. 2012, 8:457-465.
79. Ostrowski K., et al. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J. Physiol. 1998, 513:889-894.
80. Steensberg A., et al. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am. J. Physiol. Endocrinol. Metab. 2003, 285:E433-E437.
81. Grant R.W., Dixit V.D. Mechanisms of disease: inflammasome activation and the development of type 2 diabetes. Front. Immunol. 2013, 4:50.
82. Feuerer M., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009, 15:930-939.
83. Kosteli A., et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 2010, 120:3466-3479.